New research reveals vascular-associated fibroblastic cells (VAFs) role in type 1 diabetes. A $3.2M grant will explore VAFs, immune response, and potential treatments for this autoimmune disease.
Johns Hopkins researchers found boosting immune defenses prevents cancer recurrence and boosts survival. Activating T and B cells transforms 'cold' tumors, enhancing immunotherapy and radiation treatment effectiveness.
Long-lasting endurance training boosts the immune system in older adults by enhancing NK cell function, reducing inflammation, and improving metabolic control. Exercise combats cellular aging.
Amyloid beta, a protein linked to Alzheimer's, strengthens T-cells, boosting immunity against cancer. Preserving mitochondria and managing fumarate are key. This reveals a potential link between Alzheimer's and cancer defense.
Research reveals that restricted blood circulation (ischemia) drives cancer growth by reprogramming stem cells and impairing immune responses. Peripheral artery disease is linked to faster breast tumor growth.
A plant virus (CPMV) shows promise as an immunotherapy against metastatic cancer in mice. It stimulates interferons and immune responses, offering a low-cost alternative for clinical trials. Cancer cells are destroyed.
Research reveals immune system over-activation in spastic paraplegia type 15. Microglia changes and killer T-cells contribute to neuronal damage, suggesting potential immune-based therapies for this neurodegenerative disease.
